KANDACE BULLAJIAN: Open Payments
NPI 1033306303 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 23 payments from 11 companies in 2025. Trend: 2023 $391 · 2024 $619 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $173 |
| Radius Health, Inc. | 4 | $95 |
| PFIZER INC. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $32 |
| Averitas Pharma Inc. | 1 | $31 |
| Novo Nordisk Inc | 2 | $31 |
| ABBVIE INC. | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $15 |
Products named: GEMTESA, Tymlos, REXULTI, PREVNAR 20, OTEZLA, QUTENZA, QULIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
